WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors.
WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors. According to WCG, the acquisition will facilitate an increase in sharing of knowledge and communication among key stakeholders in clinical research.
Read the full release here
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
WCG Randomized 1,600 Participants for RSV Vaccine Trial
October 31st 2024A top 5 sponsor turned to WCG to recruit expecting mothers for its Phase III RSV vaccine trial. WCG support covered multiple countries and contributed almost one third of overall randomizations in the supported countries, bringing the study in ahead of schedule despite delays due to COVID-19 impacts on RSV seasonality. The sponsor met study timeline past enrollment by continuing to work with WCG’s retention support.